Use of a multi-gene pharmacogenetic panel reduces adverse drug effects.

Swen et al. examine the utility of multi-gene pharmacogenetic testing in a large multi-national cohort. They show fewer adverse drug reactions among patients receiving testing and prescribing recommendations based on genotype results compared with those receiving usual care.